RU95121629A - CRYSTALLINE COMPLEX OF CYCLODEXTRIN WITH RANITIDINE HYDROCHLORIDE, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS - Google Patents

CRYSTALLINE COMPLEX OF CYCLODEXTRIN WITH RANITIDINE HYDROCHLORIDE, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS

Info

Publication number
RU95121629A
RU95121629A RU95121629/14A RU95121629A RU95121629A RU 95121629 A RU95121629 A RU 95121629A RU 95121629/14 A RU95121629/14 A RU 95121629/14A RU 95121629 A RU95121629 A RU 95121629A RU 95121629 A RU95121629 A RU 95121629A
Authority
RU
Russia
Prior art keywords
substance
ranitidine hydrochloride
cyclodextrin
guest
host
Prior art date
Application number
RU95121629/14A
Other languages
Russian (ru)
Other versions
RU2143896C1 (en
Inventor
Фишер Вильфрид
Клоккерс Карин
Original Assignee
Хексаль Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хексаль Аг filed Critical Хексаль Аг
Priority claimed from PCT/EP1994/000645 external-priority patent/WO1994020091A1/en
Publication of RU95121629A publication Critical patent/RU95121629A/en
Application granted granted Critical
Publication of RU2143896C1 publication Critical patent/RU2143896C1/en

Links

Claims (8)

1. Комплексные соединения гидрохлорида ранитидина в качестве вещества-гостя с α-, β- и/или γ- циклодекстрином в качестве вещества-хозяина.1. Complex compounds of ranitidine hydrochloride as a guest substance with α-, β- and / or γ-cyclodextrin as a host substance. 2. Комплексные соединения по п.1, полученные с использованием в качестве вещества-гостя "формы 1" или "формы 2" гидрохлорида ранитидина. 2. The complex compounds according to claim 1, obtained using as a guest substance "form 1" or "form 2" ranitidine hydrochloride. 3. Комплексные соединения по п.1 или 2, отличающиеся тем, что молярное соотношение вещества-хозяина с веществом-гостем ≥ 1. 3. Complex compounds according to claim 1 or 2, characterized in that the molar ratio of the host substance to the guest substance is ≥ 1. 4. Способ получения комплексных соединений гидрохлорида ранитидина в качестве вещества-гостия с циклодекстрином в качестве вещества-хозяина, отличающийся тем, что приготовляют водный раствор или водную взвесь вещества-гостя и вещества-хозяина и что удаляют воду. 4. A method for producing complex compounds of ranitidine hydrochloride as a guest substance with cyclodextrin as a host substance, characterized in that an aqueous solution or an aqueous suspension of the guest substance and the host substance is prepared and that water is removed. 5. Способ по п.4, отличающийся тем, что приготовляют водный раствор или водную взвесь с содержанием β- циклодекстрина 5 - 70% и в частности 20 - 40%. 5. The method according to claim 4, characterized in that an aqueous solution or aqueous suspension is prepared with a content of β-cyclodextrin of 5 - 70% and in particular 20 - 40%. 6. Способ по п.4 или 5, отличающийся тем, что в качестве вещества-гостя используют "форму 1" или "форму 2" гидрохлорида ранитидина или что в качестве исходного материал для гидрохлорида ранитидина, служащего веществом-гостем, используют ранитидиновое основание. 6. The method according to claim 4 or 5, characterized in that as a guest substance, "form 1" or "form 2" of ranitidine hydrochloride is used or that ranitidine base is used as starting material for ranitidine hydrochloride serving as a guest substance. 7. Способ по одному из пп.4 - 6, отличающийся тем, что воду удаляют лиофилизацией, сушкой распылением, низкотемпературным вакуумным испарением или вакуумной сушкой. 7. The method according to one of claims 4 to 6, characterized in that the water is removed by lyophilization, spray drying, low temperature vacuum evaporation or vacuum drying. 8. Фармацевтический состав, включающий в качестве действующего начала комплексное соединение гидрохлорида ранитидина в качестве вещества-гостя с циклодекстрином в качестве вещества-хозяина по одному из пп.1 - 3 или полученное согласно способу по одному из пп.4 - 7 помимо обычных ингредиентов и/или добавок. 8. A pharmaceutical composition comprising, as an active ingredient, a complex compound of ranitidine hydrochloride as a guest substance with cyclodextrin as a host substance according to one of claims 1 to 3 or obtained according to the method according to one of claims 4 to 7 in addition to the usual ingredients and / or additives.
RU95121629A 1993-03-05 1994-03-04 Crystalline complex of cyclodextrin with ranitidin hydrochloride, method of preparation thereof, and pharmaceutical compositions containing thereof RU2143896C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9306024 1993-03-05
HU93.6024 1993-03-05
PCT/EP1994/000645 WO1994020091A1 (en) 1993-03-05 1994-03-04 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation

Publications (2)

Publication Number Publication Date
RU95121629A true RU95121629A (en) 1998-03-27
RU2143896C1 RU2143896C1 (en) 2000-01-10

Family

ID=10984320

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95121629A RU2143896C1 (en) 1993-03-05 1994-03-04 Crystalline complex of cyclodextrin with ranitidin hydrochloride, method of preparation thereof, and pharmaceutical compositions containing thereof

Country Status (10)

Country Link
US (1) US5665767A (en)
EP (1) EP0687174B1 (en)
JP (1) JPH09502698A (en)
AT (1) ATE201990T1 (en)
CA (1) CA2157190A1 (en)
CZ (1) CZ224995A3 (en)
DE (1) DE69427467T2 (en)
RU (1) RU2143896C1 (en)
WO (1) WO1994020091A1 (en)
ZA (1) ZA941544B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA955582B (en) * 1994-07-06 1996-02-26 Group Services Proprietary Lim Inclusion complexes of ranitidine
EP1367057B1 (en) * 1996-11-18 2008-09-17 Gesellschaft für biotechnologische Forschung mbH (GBF) Epothilones E and F
WO2000010562A1 (en) * 1998-08-18 2000-03-02 Leonidov Nikolai B Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
ITMI20012749A1 (en) * 2001-12-21 2003-06-21 Chiesi Farma Spa PROCEDURE FOR THE PREPARATION BY MICROWAVE TREATMENT OF INCLUSION COMPOUNDS BETWEEN DRUG AND CYCLODESTRINE AND PRODUCTS OBTAINED
US20040202694A1 (en) * 2003-04-11 2004-10-14 Vascular Control Systems, Inc. Embolic occlusion of uterine arteries
WO2006013039A2 (en) * 2004-08-02 2006-02-09 Chiesi Farmaceutici S.P.A. A process for the preparation of a piroxicam: beta­cyclodextrin inclusion compound
SI2044043T2 (en) 2006-06-16 2021-04-30 H. Lundbeck A/S 1- yš- (2, 4-dimethylphenylsulfanyl) -phenylćpiperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
US8889243B2 (en) 2012-08-16 2014-11-18 3M Innovative Properties Company Mechanical fastening nets and methods of making the same
WO2021079183A1 (en) * 2019-10-21 2021-04-29 Sms Pharmaceuticals Limited Isopropyl alcohol solvent free crystalline ranitidine hydrochloride form-2 which is free of nitrosamine (ndma) impurity
CA3167273A1 (en) * 2020-03-19 2021-09-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Stabilization of compounds as cyclodextrin complexes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
IT1241417B (en) * 1990-03-06 1994-01-14 Vectorpharma Int THERAPEUTIC COMPOSITIONS WITH CONTROLLED RELEASE OF DRUGS SUPPORTED ON CROSS-LINKED POLYMERS AND COATED WITH POLYMER FILM, AND THEIR PREPARATION PROCESS

Similar Documents

Publication Publication Date Title
US5800827A (en) Disinfectant composition
RU95121629A (en) CRYSTALLINE COMPLEX OF CYCLODEXTRIN WITH RANITIDINE HYDROCHLORIDE, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS
US4561997A (en) Process for the preparation of air-refreshing gels as well as the obtained gels
KR20080107425A (en) Deodorant composition
US4127647A (en) Process for preparation of stable amorphous macrolide antibiotic solids
JPS63164953A (en) Deodorizing composition
KR870002842A (en) Containing Complexes of 7-Isopropoxy-Isoflavones Prepared from Cyclodextrins and Pharmacological Compositions and Preparations Containing the Active Ingredients
ME00880B (en) Inclusion complexes of aryl-heterocyclic salts
JPS60231604A (en) Insecticidal aqueous microemulsion composition
ATE179884T1 (en) VISCOELASTIC COMPOSITIONS MADE OF ORGANIC FLUORINATED COMPOUNDS
JPH03135927A (en) Method of adjusting dry composition of low molecular organic compound
RU94042935A (en) Water-soluble complexes of benzothiophene compounds incorporation with water-soluble cyclodextrines, method of their preparing and pharmaceutical composition
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
IT1261474B (en) PROCEDURE FOR THE PREPARATION OF IODURATED BIOPOLYMERS WITH DISINFECTANT AND CICATRIZING ACTIVITY, AND IODURATED BIOPOLYMERS SO OBTAINED.
US4608366A (en) Oral cyclodextrin and mobenzoxamine preparation
JPS626449B2 (en)
KR937000160A (en) Inclusion compound of cyclodextrin and nimesulide
JPH01305043A (en) Alcohol having suppressed evaporation tendency
WO1998008924A3 (en) Concentrated premix with reduced flammability for forming fabric softening composition
KR950701251A (en) Method for preparing a catalyst for methacrylic acid synthesis
WO1999058527A3 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
JPS59199602A (en) Repellent against noxious insect
KR910005869A (en) Stable, injectable pharmaceutical compositions for anti-neoplastic compounds having at least one ethyleneimine group and methods for their preparation
AU619532B2 (en) Cyclic amp derivative ointments
JPS56150039A (en) Clathrate compound of prostacycline derivative